On these pages you can check out the latest breast cancer news from BCAC and our member groups. We also provide up-to-date information and links to current breast cancer research and clinical trials. Read latest stories below, or use the filters or the pager below for other stories. Use the form to the right of this to subscribe to our e-News.
We note that PHARMAC reported in June 2017 that the special $3.2 million fund they set up in 2007 to fund the SOLD Herceptin trial...
BCAC is thrilled a clinical trial involving American engineer Judy Perkins has led to her being declared free of breast cancer with what specialists are calling an extended remission. This wonderful news has come two years after she was told she had only three months to live.
The trial of the experimental therapy was carried out by the US National Cancer Institute. BCAC are aware there is still much to learn before scientists can turn this experimental therapy into a treatment.
More women with the most common form of early stage breast cancer may not need chemotherapy and may instead rely on hormone therapies, according to a landmark study.
The findings in the study were based on a 21-tumor gene expression test which would also inform treatment decisions in real life.
American researchers have hopes a new blood test they have developed may in the future be able to detect 10 types of cancer potentially years before someone becomes unwell.
Recent research has found that changing to a low-fat diet may have a positive influence on breast cancer outcomes.
A study led by Dr Rowan T Chlebowski, PhD of the City of Hope National Medical Center in California found that, in a randomized clinical trial, a low-fat eating pattern was associated with lower risk of death after breast cancer.
In the most comprehensive study ever looking at the genetics of breast cancer, scientists have linked 110 genes to an increased risk of the disease.
The Institute of Cancer Research study used a pioneering genetic technique to analyse 63 areas of the genome that had previously been associated with the risk of breast cancer.
New research from the UK shows how alcohol damages DNA in stem cells and helps to explain why drinking can increase your risk of cancer.
The study, by scientists at the MRC Laboratory of Molecular Biology in Cambridge has been published in the journal Nature, and used mice to show how alcohol exposure leads to permanent genetic damage.
Researchers in the US have identified two new genes associated with breast cancer: MSH6 and PMS2.
The new study suggests that each gene approximately doubles a woman’s risk of developing breast cancer by age 60. The two genes were previously known to cause Lynch syndrome, an inherited condition that raises the risk of colorectal, ovarian, stomach, and endometrial cancer.
A new study has found that acupuncture significantly reduces joint pain for post-menopausal women with early-stage breast cancer taking aromatase inhibitors.
The research, presented at the San Antonio Breast Cancer Symposium, involved a randomised controlled trial comparing acupuncture, sham acupuncture and no acupuncture.
A combination of the breakthrough drug Keytruda and Herceptin is well tolerated and has clinical benefits for patients with Herceptin-resistant HER2-positive breast cancer.
The new treatment regimen was tested in a clinical trial on patients with advanced HER2-positive breast cancer that had continued to grow on Herceptin (trastuzumab) therapies.